Cyclin D1 Is Required for Transformation by Activated Neu and Is Induced through an E2F-Dependent Signaling Pathway

REFERENCES

• Albanese, C., Johnson, J., Watanabe, G., Eklund, N., Vu, D., Arnold, A., and Pestell, R. G.. 1995. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270:23589–23597
   PubMed Web of Science ®Google Scholar
• Alberts, A. S., Geneste, O., and Treisman, R.. 1998. Activation of SRF-regulated chromosomal templates by Rho-family GTPases requires a signal that also induces H4 hyperacetylation. Cell 92:475–487
   PubMedGoogle Scholar
• Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., and Saltiel, A. R.. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:27489–27494
   PubMed Web of Science ®Google Scholar
• Alroy, I., Soussan, L., Seger, R., and Yarden, Y.. 1999. Neu differentiation factor stimulates phosphorylation and activation of the Sp1 transcription factor. Mol. Cell. Biol. 19:1961–1972
   PubMedGoogle Scholar
• Amundadottir, L. T., and Leder, P.. 1998. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes. Oncogene 16:737–746
   PubMedGoogle Scholar
• Ashton, A. W., Watanabe, G., Albanese, C., Harrington, E. O., Ware, J. A., and Pestell, R. G.. 1999. Protein kinase Cδ inhibition of S-phase transition in capillary endothelial cells involves the cyclin dependent kinase inhibitor p27Kip1. J. Biol. Chem. 274:20805–20811
   PubMed Web of Science ®Google Scholar
• Bargmann, C. I., Hung, M. C., and Weinberg, R. A.. 1986. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell 45:649–657
   PubMed Web of Science ®Google Scholar
• Bartkova, J., Lukas, J., Muller, H., Lutzhoft, D., Strauss, M., and Bartek, J.. 1994. Cyclin D1 protein expression and function in human breast cancer. Int. J. Cancer 57:351–361
   Google Scholar
• Ben-Levy, R., Paterson, H. F., Marshall, C. J., and Yarden, Y.. 1994. A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP-kinase pathway. EMBO J. 13:3302–3311
   PubMed Web of Science ®Google Scholar
• Bodrug, S. E., Warner, B. J., Bath, M. L., Lindeman, G. J., Harris, A. W., and Adams, J. M.. 1994. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J. 13:2124–2130
   PubMed Web of Science ®Google Scholar
• Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Albanese, C., Pestell, R. G., and Darnell, J. E. J.. 1999. Stat3 as an Oncogene. Cell 98:295–303
   PubMed Web of Science ®Google Scholar
• Byeon, I.-J. L., Li, J., Ericson, K., Selby, T. L., Tevelev, A., Kim, H.-J., O'Maille, P., and Tsai, M.-D.. 1998. Tumor suppressor p16Ink4a: determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4. Mol. Cell 1:421–431
   PubMed Web of Science ®Google Scholar
• Caceres, A., Binder, L. I., Payne, M. R., Bender, P., Rebhun, L., and Steward, O.. 1983. Differential subcellular localization of tubulin and the microtubule-associated protein MAP2 in brain tissue as revealed by immunocytochemistry with monoclonal hybridoma antibodies. J. Neurosci. 4:394–410
   Google Scholar
• Chen, X., Azizkhan, J. C., and Lee, D. C.. 1992. The binding of transcription factor Sp1 to multiple sites is required for maximal expression from the rat transforming growth factor alpha promoter. Oncogene 7:1805–1815
   PubMedGoogle Scholar
• Chou, M. M., and Blenis, J.. 1996. The 70 kDa S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Rac1. Cell 85:573–583
   PubMed Web of Science ®Google Scholar
• Clark, G. J., Cox, A. D., Graham, S. M., and Der, C. J.. 1995. Biological assays for Ras transformation. Methods Enzymol. 255:395–412
   PubMed Web of Science ®Google Scholar
• Cowley, S., Paterson, H., Kemp, P., and Marshall, C. J.. 1994. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77:841–852
   PubMed Web of Science ®Google Scholar
• Dickens, M., Rogers, J. S., Cavanagh, J., Raitano, A., Xia, Z., Halpern, J. R., Greenberg, M. E., Sawyers, C. L., and Davis, R. J.. 1997. A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 277:693–696
   PubMed Web of Science ®Google Scholar
• Diehl, J. A., and Sherr, C. J.. 1997. A dominant negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation of CDK-activating kinase. Mol. Cell. Biol. 17:7362–7374
   PubMed Web of Science ®Google Scholar
• Diehl, J. A., Zindy, F., and Sherr, C. J.. 1997. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev. 11:957–972
   PubMed Web of Science ®Google Scholar
• Earp, H. S., Dawson, T. L., Li, X., and Yu, H.. 1995. Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research. Breast Cancer Res. Treat. 35:115–132
   PubMed Web of Science ®Google Scholar
• Flemington, E. K., Speck, S. H., and Kaelin, W. G. J.. 1993. E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. USA 90:6914–6918
   PubMed Web of Science ®Google Scholar
• Galbiati, F., Volonte, D., Engelman, J. A., Watanabe, G., Burk, R., Pestell, R. G., and Lisanti, M. P.. 1998. Targeted Down-regulation of caveolin-1 is sufficient to drive cell transformation and activate the p42/p44 MAP kinase cascade. EMBO J. 17:6633–6648
   PubMed Web of Science ®Google Scholar
• Guy, C. T., Cardiff, R. D., and Muller, W. J.. 1996. Activated neu induces rapid tumor progression. J. Biol. Chem. 271:7673–7678
   PubMed Web of Science ®Google Scholar
• Guy, C. T., Webster, M. A., Schaller, M., Parson, T. J., Cardiff, R. D., and Muller, W. J.. 1992. Expression of the neu proto-oncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl. Acad. Sci. USA 89:10578–10582
   PubMed Web of Science ®Google Scholar
• Hirai, H., and Sherr, C.. 1996. Interaction of D-type cyclins with a novel Myb-like transcription factor, DMP1. Mol. Cell. Biol. 16:6457–6467
   PubMed Web of Science ®Google Scholar
• Janes, P. W., Daly, R. J., deFazio, A., and Sutherland, R. L.. 1994. Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2. Oncogene 9:3601–3608
   PubMed Web of Science ®Google Scholar
• Jardines, L., Weiss, M., Fowble, B., and Greene, M.. 1993. neu (c-erbB-2/HER2) and the epidermal growth factor receptor (EGFR) in breast cancer. Pathobiology 61:268–282
   PubMed Web of Science ®Google Scholar
• Joyce, D., Bouzahzah, B., Fu, M., D'Amico, M., Albanese, C., Steer, J., Klein, J. U., Lee, R. J., Segal, J. D., Westwick, J. K., Der, C. J., and Pestell, R. G.. 1999. Integration of Rac-dependent regulation of cyclin D1 transcription through an NF-kB-dependent pathway. J. Biol. Chem. 274:25245–25249
   PubMed Web of Science ®Google Scholar
• Karlseder, J., Rotheneder, H., and Wintersberger, E.. 1996. Interaction of Sp1 with growth- and cell cycle-regulated transcription factor E2F. Mol. Cell. Biol. 16:1659–1667
   PubMed Web of Science ®Google Scholar
• Lacroix, H., Iglehart, J. D., Skinner, M. A., and Kraus, M. H.. 1989. Overexpression of erbB-2 or EGF-receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastasis. Oncogene 4:145–151
   PubMed Web of Science ®Google Scholar
• Lammie, G. A., Fantl, V., Smith, R., Schuuring, E., Brookes, S., Michalides, R., Dickson, C., Arnold, A., and Peters, G.. 1991. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene 6:439–444
   PubMed Web of Science ®Google Scholar
• Lee, R. J., Albanese, C., Stenger, R. J., Watanabe, G., Inghirami, G., Haines, G. K.III, Webster, M., Muller, W. J., Brugge, J. S., Davis, R., and Pestell, R. G.. 1999. pp60v-src induction of cyclin D1 requires collaborative interactions between the ERK, p38 and Jun kinase pathways: a role for CREB and ATF-2 in pp60v-src signaling in breast cancer cells. J. Biol. Chem. 274:7341–7350
   PubMed Web of Science ®Google Scholar
• Li, R., Hannon, G. J., Beach, D., and Stillman, B.. 1996. Subcellular distribution of p21 and PCNA in normal and repair-deficient cells following DNA damage. Curr. Biol. 6:189–199
   PubMedGoogle Scholar
• Liu, J.-J., Chao, J.-R., Jiang, M.-C., Ng, S.-Y., Yen, J. J.-Y., and Yang-Yen, H.-F.. 1995. Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells. Mol. Cell. Biol. 15:3654–3663
   PubMed Web of Science ®Google Scholar
• Lukas, J., Bartkova, J., and Bartek, J.. 1996. Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D–cyclin-dependent kinase–pRb-controlled G1 checkpoint. Mol. Cell. Biol. 16:6917–6925
   PubMed Web of Science ®Google Scholar
• Lukas, J., Bartkova, J., Rohde, M., Srauss, M., and Bartek, J.. 1995. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol. Cell. Biol. 15:2600–2611
   PubMed Web of Science ®Google Scholar
• Matsumura, I., Kitamura, T., Wakao, H., Tanaka, H., Hashimoto, K., Albanese, C., Downward, J., Pestell, R. G., and Kanakura, Y.. 1999. Transcriptional regulation of cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells. EMBO J. 18:101–111
   Google Scholar
• Miltenyi, S., Muller, W., Weichel, W., and Radbruch, A.. 1990. High gradient magnetic cell separation with MACS. Cytometry 11:231–238
   PubMedGoogle Scholar
• Minden, A., Lin, A., Claret, F.-X., Abo, A., and Karin, M.. 1995. Selective activation of the JNK signalling cascade and c-jun transcriptional activity by the small GTPases RAC and Cdc42Hs. Cell 81:1147–1157
   PubMed Web of Science ®Google Scholar
• Muller, W. J., Sinn, E., Pattengale, P. K., Wallace, R., and Leder, P.. 1988. Single step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54:105–115
   PubMed Web of Science ®Google Scholar
• Musgrove, E. A., Lee, C. S., Buckley, M. F., and Sutherland, R. L.. 1994. Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc. Natl. Acad. Sci. USA 91:8022–8026
   PubMed Web of Science ®Google Scholar
• Muthuswamy, S. K., Siegel, P. M., Dankort, D. L., Webster, M. A., and Muller, W. J.. 1994. Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity. Mol. Cell. Biol. 14:735–743
   PubMed Web of Science ®Google Scholar
• Nehls, M. C., Grapilon, M. L., and Brenner, D. A.. 1992. NF-I/Sp1 switch elements regulate collagen alpha 1(I) gene expression. DNA Cell. Biol. 11:443–452
   PubMed Web of Science ®Google Scholar
• Neuman, E., Ladha, M., Lin, N., Upton, T. M., Miller, S. J., DiRenzon, J., Pestell, R. G., Hinds, P. W., Dowdy, S. F., Brown, M., and Ewen, M. E.. 1997. Cyclin D1 stimulation of estrogen receptor transcription independent of Cdk4 activation. Mol. Cell. Biol. 17:5338–5347
   PubMed Web of Science ®Google Scholar
• Paulus, W., Baur, I., Boyce, F. M., Breakefield, X. O., and Reeves, S. A.. 1996. Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. J. Virol. 70:62–67
   PubMed Web of Science ®Google Scholar
• Peles, E., and Yarden, Y.. 1993. Neu and its ligands: from an oncogene to neural factors. Bioessays 15:815–824
   PubMed Web of Science ®Google Scholar
• Pietras, R. J., Arboleda, J., Reese, D. M., Wongvipat, N., Pegram, M. D., Ramos, L., Gorman, C. M., Parker, M. G., Sliwkowski, M. X., and Slamon, D. J.. 1995. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene 10:2435–2446
   PubMed Web of Science ®Google Scholar
• Pinkas-Kramarski, R., Soussan, L., Waterman, H., Levkowitz, G., Alroy, I., Klapper, L., Lavi, S., Seger, R., Ratzkin, B. J., Sela, M., and Yarden, Y.. 1996. Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J. 15:2452–2467
   PubMed Web of Science ®Google Scholar
• Proud, C. G.. 1996. p70 S6 kinase: an enigma with variations. Trends Biochem. Sci. 21:181–185
   PubMedGoogle Scholar
• Qian, X., Dougall, W. C., Fei, Z., and Greene, M. I.. 1995. Intermolecular association and trans-phosphorylation of different neu-kinase forms permit SH2-dependent signaling and oncogenic transformation. Oncogene 10:211–219
   PubMedGoogle Scholar
• Qiu, R. G., Chen, J., Kirn, D., McCormick, F., and Symons, M.. 1995. An essential role for Rac in Ras transformation. Nature 374:457–459
   PubMed Web of Science ®Google Scholar
• Qiu, R. G., Chen, J., McCormick, F., and Symons, M.. 1995. A role for Rho in Ras transformation. Proc. Natl. Acad. Sci. USA 92:11781–11785
   PubMed Web of Science ®Google Scholar
• Resnitzky, D., and Reed, S. I.. 1995. Different roles for cyclins D1 and E in regulation of the G1-to-S transition. Mol. Cell. Biol. 15:3463–3469
   PubMed Web of Science ®Google Scholar
• Scherer, P. E., Lewis, R. Y., Volonte, D., Engelman, J. A., Galbiati, F., Couet, J., Kohtz, D. S., van Donselaar, E., Peters, P., and Lisanti, M. P.. 1997. Cell-type and tissue-specific expression of caveolin-2: caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J. Biol. Chem. 272:29337–29346
   PubMed Web of Science ®Google Scholar
• Schuuring, E., Verhoeven, E., Mooi, W. J., and Michalides, R. J.. 1992. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 7:355–361
   PubMed Web of Science ®Google Scholar
• Sherr, C. J.. 1996. Cancer cell cycles. Science 274:1672–1677
   PubMed Web of Science ®Google Scholar
• Shin, T. H., Paterson, A. J., Grant, J. H. 3., Meluch, A. A., and Kudlow, J. E.. 1992. 5-Azacytidine treatment of HA-A melanoma cells induces Sp1 activity and concomitant transforming growth factor alpha expression. Mol. Cell. Biol. 12:3998–4006
   PubMedGoogle Scholar
• Sicinski, P., Donaher, J. L., Parker, S. B., Li, T., Fazeli, A., Gardner, H., Haslam, S. Z., Bronson, R. T., Elledge, S. J., and Weinberg, R. A.. 1995. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82:621–630
   PubMed Web of Science ®Google Scholar
• Siebenkotten, G., Behrens-Jung, U., Miltenyi, S., Petry, K., and Radbruch, A.. 1998. Employing surface markers for the selection of transfected cells Cell separation methods and applications. Recktenwald, D., and Radbruch, A. 271–281 Marcel Dekker, New York, N.Y
   Google Scholar
• Siegel, P. M., Dankort, D. L., Hardy, W. R., and Muller, W. J.. 1994. Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. Mol. Cell. Biol. 14:7068–7077
   PubMed Web of Science ®Google Scholar
• Siegel, P. M., Ryan, E. D., Cardiff, R. D., and Muller, W. J.. 1999. Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer. EMBO J. 18:2149–2164
   PubMed Web of Science ®Google Scholar
• Sif, S., and Gilmore, T. D.. 1994. Interaction of the v-Rel oncoprotein with cellular transcription factor Sp1. J. Virol. 68:7131–7138
   PubMedGoogle Scholar
• Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., and McGuire, W. L.. 1987. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177–182
   PubMed Web of Science ®Google Scholar
• Solomon, M. J., Larsen, P. L., and Varshavsky, A.. 1988. Mapping protein-DNA interactions in vivo with formaldehyde: evidence that histone H4 is retained on a highly transcribed gene. Cell 53:937–947
   PubMed Web of Science ®Google Scholar
• Tao, Y., Kassatly, R. F., Cress, W. D., and Horowitz, J. M.. 1997. Subunit composition determines E2F DNA-binding site specificity. Mol. Cell. Biol. 17:6994–7007
   PubMed Web of Science ®Google Scholar
• Van Aelst, L., and D'Souza-Schorey, C.. 1997. Rho GTPases and signaling networks. Genes Dev. 11:2295–2322
   PubMed Web of Science ®Google Scholar
• Wallasch, C., Weiss, F. U., Niederfellner, G., Jallal, B., Issing, W., and Ullrich, A.. 1995. Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3. EMBO J. 14:4267–4275
   PubMed Web of Science ®Google Scholar
• Wang, T. C., Cardiff, R. D., Zukerberg, L., Lees, E., Arnold, A., and Schmidt, E. V.. 1994. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:669–671
   PubMed Web of Science ®Google Scholar
• Watanabe, G., Albanese, C., Lee, R. J., Reutens, A., Vairo, G., Henglein, B., and Pestell, R. G.. 1998. Inhibition of cyclin D-kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1. Mol. Cell. Biol. 18:3212–3222
   PubMed Web of Science ®Google Scholar
• Watanabe, G., Howe, A., Lee, R. J., Albanese, C., Shu, I.-W., Karnezis, A., Zon, L., Kyriakis, J., Rundell, K., and Pestell, R. G.. 1996. Induction of cyclin D1 by simian virus 40 small tumor antigen. Proc. Natl. Acad. Sci. USA 93:12861–12866
   PubMed Web of Science ®Google Scholar
• Watanabe, G., Lee, R. J., Albanese, C., Rainey, W. E., Batlle, D., and Pestell, R. G.. 1996. Angiotensin II (AII) activation of cyclin D1-dependent kinase activity. J. Biol. Chem. 271:22570–22577
   PubMed Web of Science ®Google Scholar
• Weinberg, R. A.. 1996. E2F and cell proliferation: a world turned upside down. Cell 85:457–459
   PubMed Web of Science ®Google Scholar
• Weinberg, R. A.. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323–330
   PubMed Web of Science ®Google Scholar
• Weinstat-Saslow, D., Merino, M. J., Manrow, R. E., Lawrence, J. A., Bluth, R. F., Wittenbel, K. D., Simpson, J. F., Page, D. L., and Steeg, P. S.. 1995. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nat. Med. 1:1257–1259
   PubMed Web of Science ®Google Scholar
• Westwick, J. K., Lambert, Q. T., Clark, G. J., Symons, M., Van Aelst, L., Pestell, R. G., and Der, C. J.. 1997. Rac regulation of transformation, gene expression, and actin organization by multiple, PAK-independent pathways. Mol. Cell. Biol. 17:1324–1335
   PubMed Web of Science ®Google Scholar
• Wymann, M. P., Bulgarelli-Leva, G., Zvelebil, M. J., Pirola, L., Vanhaesebroeck, B., Waterfield, M. D., and Panayotou, G.. 1996. Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction. Mol. Cell. Biol. 16:1722–1733
   PubMed Web of Science ®Google Scholar
• Xie, Y., Li, K., and Hung, M.-C.. 1995. Tyrosine phosphorylation of Shc proteins and formation of Shc/Grb2 complex correlate to the transformation of NIH3T3 cells mediated by the point-mutation activated neu. Oncogene 10:2409–2413
   PubMed Web of Science ®Google Scholar
• Xiong, W., Pestell, R. G., and Rosner, M. R.. 1997. Role of cyclins in neuronal differentiation of immortalized hippocampal cells. Mol. Cell. Biol. 17:6585–6597
   PubMedGoogle Scholar
• Xu, G., Livingston, D. M., and Krek, W.. 1995. Multiple members of the E2F transcription factor family are the products of oncogenes. Proc. Natl. Acad. Sci. USA 92:1357–1361
   PubMed Web of Science ®Google Scholar
• Ye, J., Xu, R. H., Taylor-Papadimitriou, J., and Pitha, P. M.. 1996. Sp1 binding plays a critical role in Erb-B2- and v-ras-mediated downregulation of α2-integrin expression in human mammary epithelial cells. Mol. Cell. Biol. 16:6178–6189
   PubMedGoogle Scholar
• Zerfass-Thome, K., Schulze, A., Zwerschke, W., Vogt, B., Helin, K., Bartek, J., Henglein, B., and Jansen-Durr, P.. 1997. p27KIP1 blocks cyclin E-dependent transactivation of cyclin A gene expression. Mol. Cell. Biol. 17:407–415
   PubMedGoogle Scholar
• Zwijsen, R. M. L., Klompmaker, R., Wientjens, E. B. H. G. M., Kristel, P. M. P., van der Burg, B., and Michalides, R. J. A. M.. 1996. Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit. Mol. Cell. Biol. 16:2554–2560
   PubMed Web of Science ®Google Scholar